Humana Inc. (NYSE:HUM) Shares Acquired by CKW Financial Group

CKW Financial Group lifted its position in Humana Inc. (NYSE:HUM) by 90.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 525 shares of the insurance provider’s stock after acquiring an additional 250 shares during the period. CKW Financial Group’s holdings in Humana were worth $133,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in the company. Pacer Advisors Inc. boosted its stake in Humana by 58.5% during the 4th quarter. Pacer Advisors Inc. now owns 15,579 shares of the insurance provider’s stock worth $3,953,000 after purchasing an additional 5,750 shares during the last quarter. KBC Group NV lifted its stake in shares of Humana by 26.0% in the fourth quarter. KBC Group NV now owns 48,685 shares of the insurance provider’s stock worth $12,352,000 after buying an additional 10,039 shares in the last quarter. Blue Trust Inc. boosted its position in Humana by 15.3% during the fourth quarter. Blue Trust Inc. now owns 1,692 shares of the insurance provider’s stock worth $429,000 after acquiring an additional 224 shares during the last quarter. Kingswood Wealth Advisors LLC grew its stake in Humana by 23.0% during the 4th quarter. Kingswood Wealth Advisors LLC now owns 9,379 shares of the insurance provider’s stock valued at $2,380,000 after acquiring an additional 1,751 shares in the last quarter. Finally, Exchange Traded Concepts LLC raised its holdings in Humana by 8.5% in the 4th quarter. Exchange Traded Concepts LLC now owns 1,191 shares of the insurance provider’s stock valued at $302,000 after acquiring an additional 93 shares during the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Humana Stock Performance

NYSE:HUM opened at $294.47 on Monday. The company has a market cap of $35.46 billion, a price-to-earnings ratio of 26.08, a price-to-earnings-growth ratio of 2.15 and a beta of 0.55. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $406.46. The company has a fifty day simple moving average of $274.39 and a two-hundred day simple moving average of $304.27.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping the consensus estimate of $3.48 by $0.68. The company had revenue of $29.30 billion for the quarter, compared to the consensus estimate of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. As a group, equities analysts anticipate that Humana Inc. will post 16.11 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on HUM. Oppenheimer dropped their price target on Humana from $400.00 to $280.00 and set an “outperform” rating for the company in a research report on Thursday, October 3rd. Bank of America raised Humana from an “underperform” rating to a “neutral” rating and raised their target price for the stock from $247.00 to $308.00 in a research note on Wednesday, November 6th. Morgan Stanley boosted their price target on shares of Humana from $288.00 to $301.00 and gave the company an “equal weight” rating in a research report on Tuesday, December 17th. Piper Sandler raised their price objective on shares of Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a research report on Wednesday, January 15th. Finally, KeyCorp began coverage on shares of Humana in a research note on Friday, October 11th. They set a “sector weight” rating on the stock. Nineteen equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $297.68.

Insider Buying and Selling at Humana

In other news, insider Timothy S. Huval sold 3,703 shares of the company’s stock in a transaction dated Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the transaction, the insider now directly owns 8,181 shares of the company’s stock, valued at approximately $2,096,463.06. This represents a 31.16 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 0.32% of the company’s stock.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.